CUFinder

Erica Golemis

Erica Golemis

Temple University

H-index: 80

North America-United States

Contact Erica Golemis

About Erica Golemis

Erica Golemis, With an exceptional h-index of 80 and a recent h-index of 37 (since 2020), a distinguished researcher at Temple University, specializes in the field of Cancer, Targeted therapy, Signal Transduction, Polycystic Kidney Disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

Molecular investigation of a polymorphic variant in JMJD1C that associates with chemoradiotherapy outcomes in locally advanced rectal and head and neck cancer

Synergy of EGFR and AURKA inhibitors in KRAS-mutated non-small cell lung cancers

Novel biomarkers that predict response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Abstract PR013: Association of a polymorphic variant in JMJD1C with response to chemoradiotherapy in rectal cancer and head and neck cancer: Implications for a diverse population

Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer

Abstract PO-024: Analysis of the NOTCH pathway in HNSCC: A target with a wide prognostic and therapeutic potential

Abstract PO-032: Association of a polymorphic variant in JMJD1C with tumor recurrence after adjuvant chemoradiation therapy in head and neck squamous cell …

Loss of Pkd1 limits susceptibility to colitis and colorectal cancer

Erica Golemis Information

University

Position

Professor, Co-Chair Molecular Therapeutics, Fox Chase Cancer Center

Citations(all)

21373

Citations(since 2020)

5656

Cited By

17808

hIndex(all)

80

hIndex(since 2020)

37

i10Index(all)

191

i10Index(since 2020)

122

Email

University Profile Page

Google Scholar

Erica Golemis Skills & Research Interests

Cancer

Targeted therapy

Signal Transduction

Polycystic Kidney Disease

Top articles of Erica Golemis

Molecular investigation of a polymorphic variant in JMJD1C that associates with chemoradiotherapy outcomes in locally advanced rectal and head and neck cancer

Cancer Research

2024/3/22

Adria Hasan
Adria Hasan

H-Index: 6

Elena V Demidova
Elena V Demidova

H-Index: 1

Karthik Devarajan
Karthik Devarajan

H-Index: 26

Synergy of EGFR and AURKA inhibitors in KRAS-mutated non-small cell lung cancers

Cancer Research Communications

2024/4/19

Tetyana Bagnyukova
Tetyana Bagnyukova

H-Index: 20

Novel biomarkers that predict response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Cancer Research

2024/3/22

Adria Hasan
Adria Hasan

H-Index: 6

Elena V Demidova
Elena V Demidova

H-Index: 1

Karthik Devarajan
Karthik Devarajan

H-Index: 26

Abstract PR013: Association of a polymorphic variant in JMJD1C with response to chemoradiotherapy in rectal cancer and head and neck cancer: Implications for a diverse population

Cancer Epidemiology, Biomarkers & Prevention

2023/12/1

Adria Hasan
Adria Hasan

H-Index: 6

Shreya Shah
Shreya Shah

H-Index: 3

Karthik Devarajan
Karthik Devarajan

H-Index: 26

Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer

NPJ Genomic Medicine

2023/11/24

Abstract PO-024: Analysis of the NOTCH pathway in HNSCC: A target with a wide prognostic and therapeutic potential

Clinical Cancer Research

2023/9/15

Andrew Elliott
Andrew Elliott

H-Index: 12

Erica Golemis
Erica Golemis

H-Index: 39

Abstract PO-032: Association of a polymorphic variant in JMJD1C with tumor recurrence after adjuvant chemoradiation therapy in head and neck squamous cell …

Clinical Cancer Research

2023/9/15

Adria Hasan
Adria Hasan

H-Index: 6

Elena V Demidova
Elena V Demidova

H-Index: 1

Karthik Devarajan
Karthik Devarajan

H-Index: 26

Loss of Pkd1 limits susceptibility to colitis and colorectal cancer

Oncogenesis

2023/8/5

Anna A Kiseleva
Anna A Kiseleva

H-Index: 4

Yan Zhou
Yan Zhou

H-Index: 6

Intrapancreatic fat, pancreatitis, and pancreatic cancer

2023/8

Correction: Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing

BMC genomics

2023/7/10

Elena V Demidova
Elena V Demidova

H-Index: 1

Ramilia Vlasenkova
Ramilia Vlasenkova

H-Index: 3

Simon Kelow
Simon Kelow

H-Index: 4

Tatiana Kent
Tatiana Kent

H-Index: 11

Adjustment of parameters in the yeast two-hybrid system: criteria for detecting physiologically significant protein-protein interactions

2023/4/28

Ilya Serebriiskii
Ilya Serebriiskii

H-Index: 26

Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing

BMC genomics

2023/4/24

Elena V Demidova
Elena V Demidova

H-Index: 1

Ramilia Vlasenkova
Ramilia Vlasenkova

H-Index: 3

Simon Kelow
Simon Kelow

H-Index: 4

Tatiana Kent
Tatiana Kent

H-Index: 11

Synthetic lethal targeting of AURKA in head and neck squamous cell carcinoma

Cancer Research

2023/4/4

Erica Golemis
Erica Golemis

H-Index: 39

Methods for diagnosis and treatment of patients having solid tumors

2023/2/14

Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry

bioRxiv

2023/1/10

Nan Bai
Nan Bai

H-Index: 2

Yan Xia
Yan Xia

H-Index: 23

Lan Lan
Lan Lan

H-Index: 11

Liang Xu
Liang Xu

H-Index: 6

Yanis Boumber
Yanis Boumber

H-Index: 20

John Karanicolas
John Karanicolas

H-Index: 24

Trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer growth and immune suppression via phospholipid scramblase anoctamin 6 (ANO6).

bioRxiv

2023

Charline Ogier
Charline Ogier

H-Index: 4

Zhen Lu
Zhen Lu

H-Index: 4

Battuya Bayarmagnai
Battuya Bayarmagnai

H-Index: 7

Alexander Deneka
Alexander Deneka

H-Index: 7

Ralph Francescone
Ralph Francescone

H-Index: 13

Tiffany Luong
Tiffany Luong

H-Index: 4

Janusz Franco-Barraza
Janusz Franco-Barraza

H-Index: 13

Qi Cai
Qi Cai

H-Index: 4

Yunyun Zhou
Yunyun Zhou

H-Index: 2

Bojana Gligorijevic
Bojana Gligorijevic

H-Index: 14

Jonathan Soboloff
Jonathan Soboloff

H-Index: 28

Musashi-2 (MSI2) regulation of DNA damage response in lung cancer

bioRxiv

2023

Alexander Deneka
Alexander Deneka

H-Index: 7

Christopher Lengner
Christopher Lengner

H-Index: 38

John Karanicolas
John Karanicolas

H-Index: 24

Yanis Boumber
Yanis Boumber

H-Index: 20

Defining an expanded RAS conformational landscape based on over 700 experimentally determined structures of KRAS, NRAS, and HRAS

bioRxiv

2022/2/5

An expanded classification of active, inactive, and druggable RAS conformations

bioRxiv

2022/1/1

H2-gamendazole: a new therapeutic lead for the treatment of polycystic kidney disease

2022/12/1

See List of Professors in Erica Golemis University(Temple University)

Co-Authors

academic-engine

Useful Links

List of top 50 universities
List of top 100 universities
List of top 500 universities
Find Professors Email
Find Universities Email
CUFinder Academic Engine